Grifols SA (GIKLY) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 8 22 sessions, October 10, 2025 to October 1, 2026
- Largest daily move
- -13.8% close of March 9, 2026
Company Description
Grifols SA (OTC: GIKLY) is classified in the drug manufacturers - general industry within the Healthcare sector and carries a market capitalization of $7.6B.
For FY2025, Grifols SA reported revenue of $8.8B with net income of $471.8M and diluted earnings per share of $0.69. The company operates at a net profit margin of 5.3%.
This page collects what Stock Titan holds for GIKLY, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
Grifols SA (GIKLY) closed at $5.55 on October 1, 2026.
GIKLY Metrics & Rankings
Price returns through October 1, 2026. Ranking links may use different dates.
Latest News
Grifols SA has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. Key topics include management, partnership, acquisition. View all GIKLY news →
SEC Filings
Grifols SA has filed 10 recent SEC filings, including 8 Form 6-K, 1 Form SCHEDULE 13G/A, 1 Form 20-F. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all GIKLY SEC filings →
Financial Highlights
Grifols SA generated $8.8B in revenue in FY2025, retaining a 38.0% gross margin, operating income reached $1.5B (16.5% operating margin), and net income was $471.8M, reflecting a 5.3% net profit margin. Diluted earnings per share stood at $0.69. The company generated $1.2B in operating cash flow. The current ratio was 2.51, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Grifols SA (GIKLY) currently stands at 1.4 thousand shares, representing 0.0% of the float. Since November 2025, short interest has increased by 1981.2%.
Days to Cover History
Days to cover for Grifols SA (GIKLY) currently stands at 44.9 days, up 18.8% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 4388%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
GIKLY Company Profile & Sector Positioning
Grifols SA (GIKLY) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing GIKLY often look at related companies in the same sector, including Ono Pharm Co (OPHLY), CSPC Pharms Grp (CSPCY), Kyowa Hakko Kogy (KYKOY), Astellas Pharma (ALPMY), and Daiichi Sankyo (DSNKY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GIKLY's relative position within its industry.